Meghmani Organics Reports Impressive Q2 Turnaround with ₹115.5 Crore Net Profit
Meghmani Organics Limited, a leading chemical manufacturer, has reported a significant financial turnaround in Q2 FY2024. The company posted a net profit of ₹115.50 crore, compared to a loss of ₹92.60 crore in Q2 FY2023. Revenue increased by 5.15% to ₹572.00 crore. EBITDA saw a substantial 70.45% rise to ₹520.90 crore, with the EBITDA margin expanding by 340 basis points to 9.02%. This performance indicates a robust recovery and improved operational efficiency for Meghmani Organics.

*this image is generated using AI for illustrative purposes only.
Meghmani Organics Limited , a leading chemical manufacturing company, has reported a significant turnaround in its financial performance for the second quarter of the fiscal year. The company's results showcase a remarkable improvement across key financial metrics, indicating a robust recovery from the challenges faced in the previous year.
Financial Highlights
| Metric | Q2 FY2024 | Q2 FY2023 | YoY Change |
|---|---|---|---|
| Net Profit | ₹115.50 crore | -₹92.60 crore | 224.73% |
| Revenue | ₹572.00 crore | ₹544.00 crore | 5.15% |
| EBITDA | ₹520.90 crore | ₹305.60 crore | 70.45% |
| EBITDA Margin | 9.02% | 5.62% | 340 bps |
Impressive Turnaround in Profitability
Meghmani Organics has demonstrated a remarkable turnaround in its profitability, posting a consolidated net profit of ₹115.50 crore in Q2. This performance stands in stark contrast to the loss of ₹92.60 crore reported in the same period last year, representing a substantial improvement in the company's bottom line.
Revenue Growth and Operational Efficiency
The company's revenue grew to ₹572.00 crore from ₹544.00 crore year-over-year, indicating a 5.15% increase. This growth in top-line performance suggests an improvement in market demand and the company's ability to capitalize on it.
Significant EBITDA Improvement
Meghmani Organics' EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) saw a substantial increase, rising to ₹520.90 crore from ₹305.60 crore in the previous year's corresponding quarter. This 70.45% jump in EBITDA reflects enhanced operational efficiency and cost management strategies implemented by the company.
Margin Expansion
The EBITDA margin improved significantly, reaching 9.02% compared to 5.62% in the previous year's quarter. This 340 basis points expansion in margin indicates the company's ability to manage costs effectively while growing its revenue, resulting in improved profitability.
Conclusion
Meghmani Organics' strong Q2 performance demonstrates a significant turnaround in its financial health. The substantial improvement across key financial metrics, including net profit, revenue, EBITDA, and EBITDA margin, reflects the company's successful efforts in overcoming previous challenges. As the chemical manufacturing sector remains competitive, stakeholders will likely monitor Meghmani Organics' future performance to assess the sustainability of this positive trend.
Historical Stock Returns for Meghmani Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.93% | -4.50% | -13.34% | -13.72% | -25.59% | -22.03% |



































